These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8911655)

  • 41. [New perspectives in immunotherapy: adhesion molecules, superantigens, heat-shock proteins and cytokine antagonists].
    Gause A; Sahin U; Pfreundschuh M
    Dtsch Med Wochenschr; 1992 Nov; 117(46):1764-73. PubMed ID: 1425297
    [No Abstract]   [Full Text] [Related]  

  • 42. B cell immunotherapy in autoimmunity--2010 update.
    Chan AC
    Mol Immunol; 2011 Jun; 48(11):1344-7. PubMed ID: 21194752
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Plasma- and lymphapheresis in autoimmune diseases].
    Schneider M
    Z Rheumatol; 1996; 55(2):90-104. PubMed ID: 8686387
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cell therapy for autoimmune diseases: does it have a future?
    Radbruch A; Thiel A
    Ann Rheum Dis; 2004 Nov; 63 Suppl 2(Suppl 2):ii96-ii101. PubMed ID: 15479883
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Immunosuppressive treatment of rheumatic diseases. Experimental bases of a rational concept of therapeutic approach (author's transl)].
    Lemmel EM; Botzenhardt U
    Arzneimittelforschung; 1976; 26(7):1281-95. PubMed ID: 1087561
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Therapeutic uses of immune suppression and enhancement.
    Schwartz RS
    Hosp Pract (Off Ed); 1981 Aug; 16(8):93-101. PubMed ID: 6266942
    [No Abstract]   [Full Text] [Related]  

  • 47. Combination therapy for multiple sclerosis: the treatment strategy of the future?
    Weinstock-Guttman B; Bakshi R
    CNS Drugs; 2004; 18(12):777-92. PubMed ID: 15377168
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Sex hormones, immune disorders, and inflammatory rheumatic diseases].
    Kaliterna DM; Perković D; Radić M; Krstulović DM; Borić K; Marinović I
    Reumatizam; 2014; 61(1):17-22. PubMed ID: 25509832
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunomodulation in autoimmune diseases.
    Gergely P; Láng I; Gonzalez-Cabello R; Fehér J
    Tokai J Exp Clin Med; 1986; 11 Suppl():207-13. PubMed ID: 3452243
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Classification of immunotherapeutic agents.
    Hadden JW
    Dev Biol Stand; 1992; 77():5-15. PubMed ID: 1426673
    [No Abstract]   [Full Text] [Related]  

  • 51. Chronic therapy with recombinant tumor necrosis factor-alpha in autoimmune NZB/NZW F1 mice.
    Gordon C; Ranges GE; Greenspan JS; Wofsy D
    Clin Immunol Immunopathol; 1989 Sep; 52(3):421-34. PubMed ID: 2758698
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunotherapy of auto-immune diseases by gene transfer.
    Chernajovsky Y; Gould D; Annenkov A; Dreja H; Daly G; Rabinovich GA; Croxford L; Baker D; Berenstein M; Podhajcer O
    Biochem Soc Trans; 1999 Dec; 27(6):869-73. PubMed ID: 10830119
    [No Abstract]   [Full Text] [Related]  

  • 53. Progress toward production of immunologic tolerance with no or minimal toxic immunosuppression for prevention of immunodeficiency and autoimmune diseases.
    Good RA
    World J Surg; 2000 Jul; 24(7):797-810. PubMed ID: 10833246
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunoadhesins for immunomodulation of autoimmune and rheumatic disease.
    Isaacs JD
    Br J Rheumatol; 1997 Mar; 36(3):305-7. PubMed ID: 9133959
    [No Abstract]   [Full Text] [Related]  

  • 55. [Immune modulation therapy in type I diabetes mellitus].
    Schmeidl R; Teuber J; Paschke R; Schwedes U; Usadel KH
    Fortschr Med; 1986 Dec; 104(45):879-83. PubMed ID: 3542769
    [No Abstract]   [Full Text] [Related]  

  • 56. Innovative rheumatology: gene and cell therapies of arthritis and related autoimmune disorders 2nd international meeting. Montpellier, France, 17-18 May 2001. Abstracts.
    Arthritis Res; 2001; 3 Suppl 1():A1-16. PubMed ID: 11458957
    [No Abstract]   [Full Text] [Related]  

  • 57. Natural history of murine lupus. Modulation by sex hormones.
    Talal N
    Arthritis Rheum; 1978 Jun; 21(5 Suppl):S58-63. PubMed ID: 352366
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intravenous immunoglobulin: an emerging treatment for immune-mediated skin diseases.
    Rütter A; Luger TA
    Curr Opin Investig Drugs; 2002 May; 3(5):713-9. PubMed ID: 12090544
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Autologous stem cell transplantation in autoimmune and rheumatic diseases: from the molecular background to clinical applications.
    Szodoray P; Varoczy L; Szegedi G; Zeher M
    Scand J Rheumatol; 2010; 39(1):1-11. PubMed ID: 20132064
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Use of immunomodulators in the management of autoimmune diseases].
    Shiokawa Y
    Nihon Rinsho; 1981 Apr; 39(4):1909-13. PubMed ID: 7310992
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.